Literature DB >> 22117909

Comparison of outcomes in patients with abandoned versus extracted implantable cardioverter defibrillator leads.

Mathieu Amelot1, Anthony Foucault, Patrice Scanu, Sophie Gomes, Laure Champ-Rigot, Arnaud Pellissier, Paul Milliez.   

Abstract

BACKGROUND: Despite the increased number of implantable cardioverter defibrillator (ICD) recipients and the frequent need for device upgrading and/or occurrence of lead malfunction, the optimal approach to managing abandoned leads remains debated. AIMS: To determine the rate and type of complications related to either abandoned or extracted ICD leads.
METHODS: Patients with abandoned or extracted leads were identified retrospectively. Patient medical records were reviewed to assess long-term lead or device malfunction, defibrillation test values before and after lead abandonment or extraction, and appropriateness of delivered shocks and subsequent surgical procedures related to devices or leads.
RESULTS: A total of 58 ICD patients with 47 extracted and 34 abandoned leads were identified. After a mean follow-up of 3.2 ± 2.6 years, the defibrillation test was not affected by either abandoned or extracted leads (23.4 ± 6.6 J vs 25.4 ± 4.9 J, respectively; P = 0.24). There were no differences in the number of ICD-related surgical procedures after extracting versus abandoning leads (22% vs 12%, respectively; P = 0.3) or in the thromboembolic event rate (7.7% vs 6.3%; P = 0.83). During follow-up, no differences in the occurrence of major complications or appropriate/inappropriate shocks were observed between patients with or without abandoned leads.
CONCLUSION: We observed no difference in rates of immediate or medium-term complications between extracting versus abandoning leads. Lead abandonment remains an alternative and safe option when extraction does not appear mandatory according to the age of the leads or experience of the operating centre.
Copyright © 2011 Elsevier Masson SAS. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 22117909     DOI: 10.1016/j.acvd.2011.08.004

Source DB:  PubMed          Journal:  Arch Cardiovasc Dis        ISSN: 1875-2128            Impact factor:   2.340


  7 in total

1.  Outcomes 1 Year After Implantable Cardioverter-Defibrillator Lead Abandonment Versus Explantation for Unused or Malfunctioning Leads: A Report from the National Cardiovascular Data Registry.

Authors:  Emily P Zeitler; Yongfei Wang; Kumar Dharmarajan; Kevin J Anstrom; Eric D Peterson; James P Daubert; Jeptha P Curtis; Sana M Al-Khatib
Journal:  Circ Arrhythm Electrophysiol       Date:  2016-07

Review 2.  A Questionable Indication For ICD Extraction After Successful VT Ablation.

Authors:  Luca Segreti; Andrea Di Cori; Giulio Zucchelli; Ezio Soldati; Giovanni Coluccia; Stefano Viani; Luca Paperini; Maria Grazia Bongiorni
Journal:  J Atr Fibrillation       Date:  2015-04-30

3.  Study Design of the Nationwide Japanese Lead Extraction (J-LEX) Registry: Protocol for a Prospective, Multicenter, Open Registry.

Authors:  Morio Shoda; Kengo Kusano; Masahiko Goya; Nobuhiro Nishii; Katsuhiko Imai; Yoji Okamoto; Misa Takegami; Yoko M Nakao; Yoshihiro Miyamoto; Akihiko Nogami
Journal:  J Arrhythm       Date:  2020-07-10

4.  Extraction of chronically implanted cardiovascular electronic device leads.

Authors:  Jeffrey Brinker
Journal:  Curr Treat Options Cardiovasc Med       Date:  2014-08

5.  Managing patients with advisory defibrillator leads: what can we learn from published data?

Authors:  F A Bracke; B M van Gelder
Journal:  Neth Heart J       Date:  2015-04       Impact factor: 2.380

6.  Frequency and clinical impact of retained implantable cardioverter defibrillator lead materials in heart transplant recipients.

Authors:  Jun Kim; Jongmin Hwang; Jin Hee Choi; Hyo-In Choi; Min-Seok Kim; Sung-Ho Jung; Gi-Byoung Nam; Kee-Joon Choi; Jae Won Lee; You-Ho Kim; Jae-Joong Kim
Journal:  PLoS One       Date:  2017-05-02       Impact factor: 3.240

7.  Erosion of Cardiovascular Implantable Device: Conservative Therapy or Extraction?

Authors:  Randa N Tabbah; Bernard Abi-Saleh
Journal:  Cureus       Date:  2020-12-11
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.